We collect cookies for vital website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Biodistribution Assessment of Lipid Nanoparticle-Mediated mRNA Delivery Using In Vivo Imaging
Application notes
Key Features
Cayman’s LNP development services in partnership with Labcorp utilizes in vivo imaging technology to create a comprehensive LNP screening platform.
With this approach, three LNP formulations were assessed in vitro and in vivo for potency of reporter gene expression and differential organ delivery.
This comprehensive LNP formulation, characterization, and analysis service can be used to identify candidate LNP formulations with tissue-tropic distribution.
To cite this application note: Rumble, J.M., Gronevelt, J.P., Snider, J., et al. Biodistribution Assessment of Lipid Nanoparticle-Mediated mRNA Delivery Using In Vivo Imaging. Application Note, Cayman Chemical (2025).
Receive Our News & Literature Directly to Your Inbox!
Log in or register to subscribe to our email list. You will receive emails packed with new products and content that match your research interests. We only email once a week and you can unsubscribe at any time.